The methylation landscape (Methylscape) of normal and malignant DNAs is different, resulting in unique self-assembly patterns in solution. The dispersion of cysteamine-capped AuNPs adsorbed onto DNA clusters could be employed to identify cancer DNA.
DNA methylation is an epigenetic alteration that results in 5-methylcytosine (5-mC) through the addition of a methyl group to the fifth carbon of a cytosine (C) residue. The methylation level, the ratio of 5-mC to C, in urine might be related to the whole-body epigenetic status and the occurrence of common cancers. To date, never before have any nanomaterials been developed to simultaneously determine C and 5-mC in urine samples. Herein, a dual-responsive fluorescent sensor for the urinary detection of C and 5-mC has been developed. This assay relied on changes in the optical properties of nitrogen-doped carbon quantum dots (CQDs) prepared by microwave-assisted pyrolysis. In the presence of C, the blue-shifted fluorescence intensity of the CQDs increased. However, fluorescence quenching was observed upon the addition of 5-mC. This was primarily due to photoinduced electron transfer as confirmed by the density functional theory calculation. In urine samples, our sensitive fluorescent sensor had detection limits for C and 5-mC of 43.4 and 74.4 μM, respectively, and achieved satisfactory recoveries ranging from 103.5 to 115.8%. The simultaneous detection of C and 5-mC leads to effective methylation level detection, achieving recoveries in the range of 104.6−109.5%. Besides, a machine learningenabled smartphone was also developed, which can be effectively applied to the determination of methylation levels (0−100%). These results demonstrate a simple but very effective approach for detecting the methylation level in urine, which could have significant implications for predicting the clinical prognosis.
Creating automation scripts for tasks involving Graphical User Interface (GUI) interactions is hard. It is challenging because not all software applications allow access to a program’s internal state, nor do they all have accessibility APIs. Although much of the internal state is exposed to the user through the GUI, it is hard to programmatically operate the GUI’s widgets.
To that end, we developed a system prototype that learns by demonstration, called
HILC
(Help, It Looks Confusing). Users, both programmers and non-programmers, train HILC to synthesize a task script by demonstrating the task. A demonstration produces the needed screenshots and their corresponding mouse-keyboard signals. After the demonstration, the user answers follow-up questions.
We propose a user-in-the-loop framework that learns to generate scripts of actions performed on visible elements of graphical applications. Although pure programming by demonstration is still unrealistic due to a computer’s limited understanding of user intentions, we use quantitative and qualitative experiments to show that non-programming users are willing and effective at answering follow-up queries posed by our system, to help with confusing parts of the demonstrations. Our models of events and appearances are surprisingly simple but are combined effectively to cope with varying amounts of supervision.
The best available baseline, Sikuli Slides, struggled to assist users in the majority of the tests in our user study experiments. The prototype with our proposed approach successfully helped users accomplish simple linear tasks, complicated tasks (monitoring, looping, and mixed), and tasks that span across multiple applications. Even when both systems could ultimately perform a task, ours was trained and refined by the user in less time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.